I don’t have an issue with your post. Fair comments about

New Post Public Reply Private Reply Replies (2) Message Board
jeff67 craigakess #78658
547
I don’t have an issue with your post. Fair comments about NP . He is a CEO of a very small OTC company so we arent going to get a Fortune 500 CEO at this level. Personally, I wish Np would leave all science related questions to Dr Kelly who is more measured in his responses whereas NPs over enthusiastic reporting wears on me also. I have mentioned many times, when this company is on the NASDAQ, NP will need to change how he presents information because large investment houses won’t tolerate dates being thrown against the wall to see if they will stick.
He has tempered his comments with the preface of “I hope...” which allows him to miss the dates he puts out there. So he damages expectations with his excitement. Coming from the Pharma business I’m not surprised we haven’t heard anything yet. Many people have already put more rational timeframes for the top line reporting on boards pointing to more of a March date which would make sense.I’m in this stock because of the drug and what I believe it can do if it gets good navigation from management . They are learning by hiring a BLA/FDA clinical trial expert . But comments by NP dating back to the summer such as why the BLA got rejected ( saying it was only a syringe issue) turned out to be absolutely false . I also believe we are not on the NaSDAQ for the discretionary reasons Mullholland mentioned. In my opinion is the settlement of the lawsuit which stated that the board over compensated management with stock and was ordered to make compliance changes to the board. This is a big deal but is being Pooh-poohed by many retailers as not a big deal. It is a big deal and why would any exchange welcome a company and it’s management team to the exchange without seeing proof that bad behavior has changed
18-24 months from now l Cytodyn will be owned by a much larger Pharma with more experienced leadership. All will reap financial reward from that acquisition. . There are tell tale signs that they will sell. If they believe they will have HIV on the market by the end of this year they would be hiring an SVP of sales and marketing right now to build the team, create the messaging , etc. it’s very hard and time consuming to find a good head of sales but we are going into March and no job posting yet..

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APP Group's New Conservation Efforts in Sumatra

Updated Category News Views 0

Taking a Bold Step Towards Conservation APP Group, in collaboration with Proforest, WWF-Indonesia, and KKI WARSI, is setting its sights on a more sustainable future with the PROTECT30 initiative. This isn't just another dime-a-dozen CSR project—it’s a concerted effort aimed at conserving Sumatra's precious Bukit Tigapuluh landscape. These folks are playing the long...

Continue Reading
Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Updated Category News Views 99

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

Continue Reading
Maxwell M1 Hybrid Unveils Game-Changing Aircraft

Updated Category News Views 122

Welcome to the Future of Amphibious Flight You ever wonder when we'd get past seeing traditional planes stuck at runways? Well, Maxwell Aircraft just fired a hefty shot across the bow with their M1 Hybrid amphibious model. This ain't your run-of-the-mill crate with wings; it's redefining what these birds can do, particularly if you're eyeing remote areas or water-based...

Continue Reading
ANDPAD Shines in Asia's 2026 Growth Company Awards

Updated Category News Views 85

AI Takes Center Stage in Construction Ever seen AI shake a dusty old industry to its core? Well, if you haven't, ANDPAD is doing just that in construction, making waves across Asia. Look, when a company like ANDPAD snags a spot in the 'NextGen Tech 30 2026,' you pay attention. That's a glitzy award for the movers and shakers in tech, and these folks are doing some serious...

Continue Reading
Crunch Fitness Invests $5M in Jurupa Valley Expansion

Updated Category News Views 54

New Era for Crunch Fitness in Jurupa Valley When you've been around the block as much as some of us have, you learn to spot the makings of a solid investment. Fitness Ventures isn't just tossing another gym into the sea of treadmills and barbells; they're making waves with their new $5 million Crunch 3.0 club in Jurupa Valley. This isn't some half-baked, pop-up fitness...

Continue Reading
Teneo Expands Financial Advisory in Canada, Eyes Talent

Updated Category News Views 48

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Continue Reading
Dr. Rod Rohrich Tops Facelift Surgeons Once Again

Updated Category News Views 57

A Consistent Top Performer in the Cosmetic Surgery World When the same name pops up as the best in their field year after year, it's not just luck—it's a testament to their skills and dedication. Newsweek has ranked Dr. Rod J. Rohrich as the top facelift surgeon in the U.S. for six consecutive years. Now that’s one heck of a streak in the cutthroat world of cosmetic...

Continue Reading
FX's Game-Changer: Stemless Reverse Shoulder System

Updated Category News Views 162

Stirring Up the Shoulder Market You gotta hand it to FX Shoulder Solutions – they've managed to elbow their way into the medical device market with something truly revolutionary. With the FDA clearance of Easytech Reversed®, a stemless reverse shoulder arthroplasty system, they're not just playing the innovation game; they're setting a whole new rulebook. This isn't...

Continue Reading
NextPlat Gears Up for Q3 2026 Earnings Call

Updated Category News Views 32

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

Continue Reading
Brian Long Exits Atlantic Bridge for US Tech Fund

Updated Category News Views 134

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering the Amazing Growth of Waste Management Stock

Updated Category News Views 150

Unveiling Waste Management's Financial Triumph Waste Management (NYSE: WM) has had a remarkable run over the past decade, consistently outperforming the broader market. With annual returns averaging 14.86%, investors have witnessed impressive growth as the company continues to thrive. The Impact of Compounding Returns The heart of investing often lies in the power of...

Continue Reading
Jasper Therapeutics Unveils Promising Briquilimab Findings

Updated Category News Views 332

Jasper Therapeutics Presents Briquilimab Data at AAAAI Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology firm known for its pioneering work, recently showcased updated findings from its clinical studies involving briquilimab, a groundbreaking antibody targeting c-Kit, aimed at treating mast cell driven diseases including chronic spontaneous urticaria (CSU) and...

Continue Reading
Cybersecurity Professionals to Command Salaries up to $270,000 in 2026

Updated Category News Views 509

Cybersecurity Salary Trends for 2026 As the demand for cybersecurity professionals continues to grow, the landscape of compensation is evolving rapidly. A recent analysis has revealed that salaries for high-clearance cybersecurity roles, particularly those requiring TS/SCI clearances with Full-Scope Polygraph, are projected to escalate significantly, reaching upwards of...

Continue Reading
Unlocking the Power of Apache Cassandra 5.0: A New Era of AI-Ready Databases

Updated Category News Views 70

Apache Software Foundation Launches Apache Cassandra 5.0 Today marks a significant milestone for database management as the Apache Software Foundation (ASF) announces the launch of Apache Cassandra 5.0. This version is set to redefine efficiency, security, and capability in handling large datasets. Revolutionary Features of Apache Cassandra 5.0 Apache Cassandra is...

Continue Reading
Discover the Thrilling History of Supercross in Pay Dirt

Updated Category News Views 496

Unveiling Supercross: The Narrative of Pay Dirt In a groundbreaking new film, Academy Award nominee Josh Brolin narrates the fascinating history of Supercross, a motorsport that began with a simple concept and evolved into a thrilling spectacle. The documentary, titled Pay Dirt: The Story of Supercross, brings to life the monumental tales surrounding this...

Continue Reading